Chemomab Therapeutics Ltd. (CMMB)
2.59
-0.10
(-3.72%)
USD |
NASDAQ |
Sep 10, 16:00
2.59
0.00 (0.00%)
After-Hours: 18:56
Chemomab Therapeutics Market Cap : 18.77M for Sept. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 09, 2026 | 19.49M |
| September 08, 2026 | 19.93M |
| September 04, 2026 | 19.64M |
| September 03, 2026 | 20.50M |
| September 02, 2026 | 19.78M |
| September 01, 2026 | 19.78M |
| August 31, 2026 | 19.71M |
| August 28, 2026 | 19.64M |
| August 27, 2026 | 19.71M |
| August 26, 2026 | 18.77M |
| August 25, 2026 | 16.66M |
| August 24, 2026 | 15.72M |
| August 21, 2026 | 15.65M |
| August 20, 2026 | 15.00M |
| August 19, 2026 | 15.14M |
| August 18, 2026 | 13.84M |
| August 17, 2026 | 13.91M |
| August 14, 2026 | 13.75M |
| August 13, 2026 | 13.68M |
| August 12, 2026 | 13.82M |
| August 11, 2026 | 13.68M |
| August 10, 2026 | 13.61M |
| August 07, 2026 | 13.90M |
| August 06, 2026 | 12.96M |
| August 05, 2026 | 12.60M |
| Date | Value |
|---|---|
| August 04, 2026 | 12.10M |
| August 03, 2026 | 11.66M |
| July 31, 2026 | 11.16M |
| July 30, 2026 | 11.02M |
| July 29, 2026 | 10.51M |
| July 28, 2026 | 10.30M |
| July 27, 2026 | 10.22M |
| July 24, 2026 | 9.792M |
| July 23, 2026 | 10.08M |
| July 22, 2026 | 10.30M |
| July 21, 2026 | 10.58M |
| July 20, 2026 | 10.80M |
| July 17, 2026 | 11.23M |
| July 16, 2026 | 10.94M |
| July 15, 2026 | 10.94M |
| July 14, 2026 | 11.02M |
| July 13, 2026 | 11.88M |
| July 10, 2026 | 12.53M |
| July 09, 2026 | 13.18M |
| July 08, 2026 | 14.18M |
| July 07, 2026 | 19.95M |
| July 06, 2026 | 17.28M |
| July 02, 2026 | 16.34M |
| July 01, 2026 | 12.24M |
| June 30, 2026 | 11.66M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioLineRx Ltd. | 11.14M |
| XTL Biopharmaceuticals Ltd. | 5.677M |
| Kamada Ltd. | 461.55M |
| Can-Fite BioPharma Ltd. | 4.692M |
| Galmed Pharmaceuticals Ltd. | 4.636M |
Market Cap Related Metrics
| Price to Book Value | 2.161 |
| Price | 2.59 |
| Earnings Yield | -39.40% |